If you've been curious about semaglutide or tirzepatide, one question comes up before all the others: do I actually qualify? The short answer is that GLP-1 medications are prescribed based on your body mass index (BMI) and your overall health picture, not just a number on a scale. Here's how clinicians decide, what the criteria mean, and who these medications aren't right for.
A quick note: this article is educational and isn't a substitute for personalized medical advice. Eligibility is always determined during a real clinical evaluation.
Who Qualifies for GLP-1 Weight Loss Medication?
The standard framework that guides most clinicians comes from FDA labeling for chronic weight management. GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition.
In plain terms, there are two main doors in:
- A BMI of 30 or above (the threshold for obesity), or
- A BMI of 27 to 29.9 (the overweight range) plus at least one weight-related health condition.
BMI is the starting point because it's the standard screening tool. Overweight and obesity are defined by body mass index (BMI), a measurement that uses your weight and height to estimate overweight and obesity. But it's genuinely just a starting point. In our practice, patients often have nearly identical BMIs but very different health profiles, which is why a thorough history matters more than any single number.
Which conditions count toward the BMI 27+ pathway?
If your BMI sits in the 27 to 29.9 range, a qualifying weight-related condition opens the door. Commonly recognized examples include cardiovascular conditions such as coronary heart disease, hypertension, dyslipidemia, diabetes, elevated waist circumference, or another obesity-related medical condition like sleep apnea.
These conditions aren't random. They tend to travel with excess weight. Research consistently shows that risk rises as BMI climbs: the risk of obstructive sleep apnoea, type 2 diabetes, hip and knee osteoarthritis, and asthma increases significantly with increasing BMI. That's a big part of why treating obesity early, as a medical condition rather than a willpower problem, can pay off across the rest of your health.
Why Doctors Look Beyond BMI
BMI doesn't measure body composition, where you carry weight, or your metabolic health. A muscular person can have a "high" BMI without excess fat, and someone in the overweight range may already have several metabolic red flags. That's why the medical conversation always includes more than height and weight.
We also factor in your history with weight. Many people arrive having tried, sincerely and repeatedly, to lose weight through diet and exercise alone. That history is clinically meaningful, not a mark against you, because it helps establish why medical treatment is appropriate. If you're weighing whether the timing is right, our team walks through it on how it works.
How GLP-1 Medications Actually Work
Understanding the mechanism helps explain why the eligibility criteria are built the way they are. GLP-1 (glucagon-like peptide-1) is a natural gut hormone, and these medications mimic it. GLP-1 receptor activation slows gastric emptying, inhibits the release of glucagon, and stimulates insulin production, thereby improving glucose homeostasis.
There are two effects that matter most for weight:
- Slowed digestion. By slowing gastric emptying, it takes longer for food to leave your stomach, which keeps you feeling full longer and tends to change how much you eat.
- Appetite signaling in the brain. GLP-1 receptor agonists also drive central appetite regulation: reduced hunger and increased satiety through hypothalamic pathways.
Together, the satiety effect reduces food intake, appetite and hunger, and these combined effects often result in weight loss. This is also why nutrition and protein intake matter so much during treatment. You can read more on our medications page.
Who Should Not Take GLP-1 Medications
Qualifying isn't only about meeting the BMI bar. It's also about ruling out reasons these drugs aren't safe for you. The clearest red lines come straight from the labeling. For most GLP-1 medications, the FDA lists two true contraindication categories: personal or family history of medullary thyroid carcinoma (MTC) or MEN2, and known serious hypersensitivity to the medication.
A few other situations call for caution rather than an automatic no. According to FDA guidance, GLP-1 medications are generally not recommended in pregnancy, because safety data are limited; with a prior history of pancreatitis, due to a risk of triggering inflammation of the pancreas; or with a history of medullary thyroid carcinoma or MEN2.
It's worth keeping the thyroid concern in perspective. The FDA boxed warning says GLP-1 receptor agonists should not be used in patients with MTC history or MEN2, and this warning exists because of rodent toxicology studies. Notably, a family history of papillary, follicular, or Hürthle cell thyroid cancer is not a contraindication, which is exactly the kind of nuance a careful clinical review is meant to sort out.
Is It Right for You?
Meeting the BMI threshold doesn't automatically mean a GLP-1 is the best choice, and not meeting it doesn't always close the door, since oral options and other tools exist. Our care is led by Dr. Tran Le, MD, who is triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational & Environmental Medicine. Every plan starts with a real evaluation of your history, labs where appropriate, and goals.
For Texas and Utah patients, this all happens online. Our memberships keep it simple: all-inclusive compounded semaglutide or tirzepatide with the medication included, plus an à la carte plan for brand-name GLP-1s. You can compare the details on our pricing page. (Note: compounded medications are not FDA-approved.)
Frequently Asked Questions
What BMI do you need to qualify for semaglutide or tirzepatide?
Generally a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea. A clinician confirms eligibility during your visit.
Can I qualify if my BMI is under 27?
Usually not for weight management, because there's limited safety and effectiveness data in that range and the risk-benefit balance shifts. Your provider can talk through alternatives that may fit your situation better.
Does a family history of thyroid cancer disqualify me?
It depends on the type. A personal or family history of medullary thyroid carcinoma or MEN2 is a contraindication, while more common thyroid cancers generally are not. This is reviewed carefully before any prescription.
Ready to Find Out If You Qualify?
The most reliable way to know is a short, physician-led evaluation, no guessing from a BMI chart. If you're in Texas or Utah, you can start your consultation here and get a clear, honest answer about whether a GLP-1 fits your health and goals.